SE516468C2 - Användning av ett extrakt från Morinda citrifolia L. för framställning av läkemedel för behandling av tinnitus. - Google Patents

Användning av ett extrakt från Morinda citrifolia L. för framställning av läkemedel för behandling av tinnitus.

Info

Publication number
SE516468C2
SE516468C2 SE0000698A SE0000698A SE516468C2 SE 516468 C2 SE516468 C2 SE 516468C2 SE 0000698 A SE0000698 A SE 0000698A SE 0000698 A SE0000698 A SE 0000698A SE 516468 C2 SE516468 C2 SE 516468C2
Authority
SE
Sweden
Prior art keywords
extract
medicament
patient
tinnitus
body weight
Prior art date
Application number
SE0000698A
Other languages
English (en)
Swedish (sv)
Other versions
SE0000698L (de
SE0000698D0 (sv
Inventor
Bo Gidlund
Original Assignee
Bo Gidlund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bo Gidlund filed Critical Bo Gidlund
Priority to SE0000698A priority Critical patent/SE516468C2/sv
Publication of SE0000698D0 publication Critical patent/SE0000698D0/xx
Priority to DE60108227T priority patent/DE60108227D1/de
Priority to PCT/SE2001/000447 priority patent/WO2001064231A1/en
Priority to AU2001241315A priority patent/AU2001241315A1/en
Priority to AT01912627T priority patent/ATE286402T1/de
Priority to EP01912627A priority patent/EP1261358B1/de
Publication of SE0000698L publication Critical patent/SE0000698L/xx
Publication of SE516468C2 publication Critical patent/SE516468C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/746—Morinda
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE0000698A 2000-03-02 2000-03-02 Användning av ett extrakt från Morinda citrifolia L. för framställning av läkemedel för behandling av tinnitus. SE516468C2 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE0000698A SE516468C2 (sv) 2000-03-02 2000-03-02 Användning av ett extrakt från Morinda citrifolia L. för framställning av läkemedel för behandling av tinnitus.
DE60108227T DE60108227D1 (de) 2000-03-02 2001-03-02 Verwendung von morinda citrifolia zur behandlung von tinnitus
PCT/SE2001/000447 WO2001064231A1 (en) 2000-03-02 2001-03-02 Use of a composition
AU2001241315A AU2001241315A1 (en) 2000-03-02 2001-03-02 Use of a composition
AT01912627T ATE286402T1 (de) 2000-03-02 2001-03-02 Verwendung von morinda citrifolia zur behandlung von tinnitus
EP01912627A EP1261358B1 (de) 2000-03-02 2001-03-02 Verwendung von morinda citrifolia zur behandlung von tinnitus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0000698A SE516468C2 (sv) 2000-03-02 2000-03-02 Användning av ett extrakt från Morinda citrifolia L. för framställning av läkemedel för behandling av tinnitus.

Publications (3)

Publication Number Publication Date
SE0000698D0 SE0000698D0 (sv) 2000-03-02
SE0000698L SE0000698L (de) 2001-09-03
SE516468C2 true SE516468C2 (sv) 2002-01-15

Family

ID=20278673

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0000698A SE516468C2 (sv) 2000-03-02 2000-03-02 Användning av ett extrakt från Morinda citrifolia L. för framställning av läkemedel för behandling av tinnitus.

Country Status (6)

Country Link
EP (1) EP1261358B1 (de)
AT (1) ATE286402T1 (de)
AU (1) AU2001241315A1 (de)
DE (1) DE60108227D1 (de)
SE (1) SE516468C2 (de)
WO (1) WO2001064231A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6737089B2 (en) * 1999-08-27 2004-05-18 Morinda, Inc. Morinda citrifolia (Noni) enhanced animal food product
US8790727B2 (en) 2000-12-05 2014-07-29 Tahitian Noni International, Inc. Morinda citrifolia and iridoid based formulations
US7244463B2 (en) 2005-10-18 2007-07-17 Tahitian Noni International, Inc. Garcinia mangostana L. enhanced animal food product
US8652546B2 (en) 2007-09-06 2014-02-18 Tahitian Noni International, Inc. Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals
US8574642B2 (en) 2000-12-05 2013-11-05 Tahitian Noni International, Inc. Antiviral Morinda citrifolia L. based formulations and methods of administration
US7442395B2 (en) 2002-11-14 2008-10-28 Tahitian Noni International, Inc. Formulation for treating candidiasis using Morinda citrifolia
US8535741B2 (en) 2006-05-12 2013-09-17 Morinda, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
US8025910B2 (en) 2006-05-12 2011-09-27 Tahitian Noni International, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
EP4299059A1 (de) 2022-07-01 2024-01-03 Labelic Analysis, S.L. Zusammensetzung zur behandlung von tinnitus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409144A (en) * 1978-01-19 1983-10-11 Research Corporation Of The University Of Hawaii Xeronine, a new alkaloid, useful in medical, food and industrial fields
US5288491A (en) * 1992-09-24 1994-02-22 Herbert Moniz Noni (Morinda Citrifolia) as a pharmaceutical product

Also Published As

Publication number Publication date
EP1261358B1 (de) 2005-01-05
SE0000698L (de) 2001-09-03
DE60108227D1 (de) 2005-02-10
ATE286402T1 (de) 2005-01-15
EP1261358A1 (de) 2002-12-04
SE0000698D0 (sv) 2000-03-02
AU2001241315A1 (en) 2001-09-12
WO2001064231A1 (en) 2001-09-07

Similar Documents

Publication Publication Date Title
US6436449B2 (en) Use of a composition
Bartram Bartram's encyclopedia of herbal medicine
Mardani et al. The Effect of ginger herbal spray on reducing xerostomia in patients with type II diabetes
WO2020115751A1 (en) Cannabis-based compositions for the treatment of alzheimer's disease and dementia
Pearl et al. Herbs in epilepsy: evidence for efficacy, toxicity, and interactions
US10561694B2 (en) Pharmaceutical compositions containing cannabis, uses thereof and methods for improving sleep quality
EP1261358B1 (de) Verwendung von morinda citrifolia zur behandlung von tinnitus
KR101565159B1 (ko) 노화 및 관절염의 예방 또는 치료용 조성물
US11534473B2 (en) Composition for preventing or treating hearing loss, containing Vitis vinifera leaf extract as active ingredient
Ross Sleep disorders: a single dose administration of valerian/hops fluid extract (dormeasan) is found to be effective in improving sleep
CN110101744A (zh) 一种抗抑郁症的药物配方及其制备方法
CN112386589B (zh) 一种抗焦虑/抗抑郁药用组合物及其用途
KR20010009465A (ko) 금단증상을 억제하는 조성물
WO2019038100A1 (fr) Produit de combinaison pour soulager les symptômes liés aux infections des voies respiratoires supérieures
Chung et al. Effects of Elsholtzia splendens and Cirsium japonicum on premenstrual syndrome
US9226944B2 (en) Herbal preparation for sleep apnea relief
KR20030035482A (ko) 성기능 개선용 홍삼복합물, 용도 및 그의 제조방법
Divakar Remedy for COVID-19–Ayurveda Medicine of Anandayya
Rajarajan et al. A review on the medicinal properties of Gingko biloba.
Kalam Evaluation of anticonvulsant activity of Aqer Qerha (Anacyclus pyrethrum DC) root in experimental animals
Rohokale et al. Review on Formulation and Evaluation of Herbal Cough Syrup
Shrishrimal et al. On barks of Cinnamomomum zeylanicum Nees
KR102838311B1 (ko) Rls 치료를 위한 님
Conry et al. Herbal therapy in epilepsy
Al-Qaaneh et al. Medicinal and Nutritional Importance of Mentha piperita in Human Health

Legal Events

Date Code Title Description
NUG Patent has lapsed